Abstract:Ubiquitin-conjugating enzyme E2 J1 (UBE2J1) has been proved to participate in the ubiquitination of multiple substrate proteins. However, the underlying mechanisms of UBE2J1 as a ubiquitin-conjugating enzyme participating in cancer development and progression remain largely unknown. Here, we identified that UBE2J1 was downregulated in colorectal cancer (CRC) tissues and cell lines which were mediated by DNA hypermethylation of its promoter, and decreased UBE2J1 was associated with poor prognosis. Functionally,… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.